[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632968":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":38,"centralContacts":43,"locations":52,"responsibleParty":75,"collaborators":77,"id":85,"slug":11,"hasResults":86,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":90,"eligibilityCriteria":91,"healthyVolunteers":86,"sex":92,"minAge":93,"maxAge":94,"enrollmentInfo":95,"targetDuration":11,"studyType":98,"phases":99,"briefSummary":101,"conditions":102,"keywords":104,"overallStatus":107,"whyStopped":11,"lastUpdateSubmitDate":108,"lastUpdatePostDateStruct":109,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":117},{"fullName":5,"class":6},"University Hospital, Caen","OTHER",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Control group (usual care)","ACTIVE_COMPARATOR",null,[13],"Other: Usual care follow-up by CRCDC",{"label":15,"type":16,"description":17,"interventionNames":18},"Early letter with information leaflet about colonoscopy","EXPERIMENTAL","B1",[13,19],"Other: Information leaflet about colonoscopy follow-up",{"label":21,"type":16,"description":22,"interventionNames":23},"Early letter endorsed by the GP with information leaflet about colonoscopy","B2",[13,19,24],"Other: Endorsement of CRCDC letters from the GP",[26,30,34],{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":11},"Usual care follow-up by CRCDC","1. 6 months after positive test result: 1st reminder letter from the CRCDC if it has no information about a colonoscopy being performed\n2. 12 months after positive test result: 2nd reminder letter from the CRCDC if it has no information about a colonoscopy being performed\n3. 18 months after positive test result: 3rd reminder letter from the CRCDC if it has no information about a colonoscopy being performed",[9,21,15],{"type":6,"name":31,"description":32,"armGroupLabels":33,"otherNames":11},"Information leaflet about colonoscopy follow-up","An information leaflet about colonoscopy follow-up will be sent in an early letter 7 days after positive test result, and though QR-codes in subsequent reminders.",[21,15],{"type":6,"name":35,"description":36,"armGroupLabels":37,"otherNames":11},"Endorsement of CRCDC letters from the GP","Explicit mention of their general practitioner in letters and reminders sent by the CRCDC to individuals who have tested positive for colorectal cancer, including the information leaflet about colonoscopy or a link to this document (QR code).",[21],[39],{"name":40,"affiliation":41,"role":42},"Lydia GUITTET, MD,PhD","Caen Normandy University - INSERM U1086 ANTICIPE - Caen University Hospital","STUDY_DIRECTOR",[44,49],{"name":40,"role":45,"phone":46,"phoneExt":47,"email":48},"CONTACT","231065781","+33","lydia.guittet@unicaen.fr",{"name":50,"role":45,"phone":46,"phoneExt":47,"email":51},"Arnaud ALVES, MD,PhD","alves-a@chu-caen.fr",[53],{"facility":54,"status":11,"city":55,"state":56,"zip":57,"country":56,"countryCode":58,"cosmosGeoPoint":59,"geoPoint":64,"contacts":65},"Crcdc-Cvl","Tours","France","37000","FR",{"type":60,"coordinates":61},"Point",[62,63],0.70398,47.39484,{"lat":63,"lon":62},[66,70,73],{"name":67,"role":45,"phone":68,"phoneExt":47,"email":69},"Julie BOYARD, ScD","749702336","j.boyard@crcdc-cvl.fr",{"name":71,"role":45,"phone":11,"phoneExt":11,"email":72},"Somany VIDAL-SENGCHANH-VIDAL","s.sengchanh@depistage-cancer.fr",{"name":67,"role":74,"phone":11,"phoneExt":11,"email":11},"PRINCIPAL_INVESTIGATOR",{"type":76,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[78,80,83],{"name":79,"class":6},"Centre Regional de Coordination des Depistages des Cancer - Pays de la Loire",{"name":81,"class":82},"INSERM U1086 ANTICIPE - Université Caen Normandie","UNKNOWN",{"name":84,"class":82},"URPS Centre Val de Loire","100632968",false,"NCT07520578","EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WITH A POSITIVE COLORECTAL CANCER SCREENING TEST. (SUIVICOLO)","EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WITH A POSITIVE COLORECTAL CANCER SCREENING TEST, A RANDOMISED CONTROLLED TRIAL. (SUIVICOLO)","SUIVICOLO","Inclusion Criteria:\n\n* Aged between 50 and 75 at the time of the positive colorectal cancer screening test\n\n  * Residing in one of the departments of the Centre Val de Loire region\n  * Date on which the positive CRC screening test result was sent to the beneficiary recorded\n  * Colorectal cancer screening test results sent to the beneficiary within 30 days of the test being read\n  * Affiliated with a health insurance fund\n\nExclusion Criteria:\n\n* Subjects who have notified their refusal to allow their data to be used for research purposes will be excluded from the analyses.","ALL","50 Years","75 Years",{"count":96,"type":97},2000,"ESTIMATED","INTERVENTIONAL",[100],"PHASE3","To be effective, organized colorectal cancer screening requires good adherence to diagnostic colonoscopy in the event of a positive test. In France, the rate of diagnostic colonoscopy following a positive colorectal cancer screening test is less than 85%, and the median delay is close to 90 days. After receiving their positive result from the laboratory, individuals with no known follow-up are contacted only six months later by the Regional Cancer Screening Coordination Centers (CRCDC) responsible for following up with individuals who have tested positive. To optimize follow-up with colonoscopy, earlier contact and information about colonoscopy appear to be necessary. The contribution of the general practitioner identified on the test could be an additional lever.\n\nThe SUIVICOLO study aims to evaluate the effectiveness on the rate of colonoscopies performed at 6 months of two strategies for optimizing the follow-up of positive results in comparison with control group C (current procedures of the CRCDC Centre Val de Loire without early letter).\n\nThe two strategies evaluated will be:\n\n* Group B1: Sending an early letter signed by the CRCDC accompanied by information leaflet about colonoscopy\n* Group B2: Sending an early letter co-signed by the CRCDC and the general practitioner (identified or provided by the patient on the test identification form) accompanied by information leaflet about colonoscopy.\n\nThese strategies will be compared to the current follow-up strategy in a three arm randomized controlled arm.",[103],"Colorectal Cancer Screening",[105,106],"Colonoscopy","Fecal immunochemical test","NOT_YET_RECRUITING","2026-04-02",{"date":110,"type":111},"2026-04-09","ACTUAL",{"date":113,"type":97},"2026-03-24",{"date":115,"type":97},"2028-10-24",{"name":5,"class":6},1]